Atlas Trials

Administration of Intranasal Midazolam for Anxiety in Palliative Care

Clinical trial NCT06330584 · RECRUITING

Trial details

NCT number
NCT06330584
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
AnxietyAcute AnxietyPalliative Care
Start date
2024-12-20
Primary completion
2025-09-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.